Respiratory infections in allergic children: the preventive role of a multicomponent nutraceutical

Anna Maria Zicari1, Giovanan De Castro1, Giulia Brindisi1

  • 1Pediatrics Department , Umberto I Hospital, Roma, Sapienza University , Roma, Italy. gio.cip@libero.it.

Insights

A multicomponent nutraceutical significantly reduced respiratory infections and antibiotic use in allergic children. This finding offers a promising strategy for managing allergic rhinoconjunctivitis and combating antibiotic resistance in pediatric care.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infectious Disease Management
  • Nutraceutical Research

Background:

  • Allergic children frequently experience respiratory infections (RI), posing challenges for pediatricians.
  • Antibiotic overuse in children with allergic rhinoconjunctivitis contributes to antimicrobial resistance.
  • Modulating the immune system is a potential strategy for preventing RI in this population.

Purpose of the Study:

  • To evaluate the efficacy of a multicomponent nutraceutical in reducing RI and antibiotic use.
  • To compare outcomes in children with allergic rhinoconjunctivitis receiving a nutraceutical versus a control group.

Main Methods:

  • A prospective study involving two groups of children with allergic rhinoconjunctivitis.
  • The active group (AG) received a nutraceutical (Lertal®) before a 1-year observation period.
  • The control group (CG) did not receive the nutraceutical.
  • Primary outcomes measured were the number of RI and antibiotic courses.

Main Results:

  • Children in the AG experienced a significantly lower number of RI compared to the CG (p=0.01).
  • The AG also showed a significant reduction in antibiotic courses compared to the CG (p=0.002).

Conclusions:

  • A course of the studied multicomponent nutraceutical can effectively reduce respiratory infections in children with allergic rhinoconjunctivitis.
  • This intervention may decrease the need for antibiotic prescriptions, aiding in the fight against antibiotic resistance.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
885
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K